Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review

BACKGROUND: Cyclin-dependent kinase (CDK) 4/6 inhibitors have revolutionized the treatment landscape of hormone receptor-positive (HR(+)), human epidermal growth factor receptor 2-negative (HER2(−)) metastatic breast cancer, with an impressive efficacy and safety profile. Cytopenia is the main adver...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharaf, Baha', AlMasri, Rama, Abdel-Razeq, Nayef, Salama, Osama, Hamad, Ibrahim, Abunasser, Mahmoud, Abdel-Razeq, Hikmat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743357/
https://www.ncbi.nlm.nih.gov/pubmed/35023941
http://dx.doi.org/10.2147/CCID.S344867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743357/
https://www.ncbi.nlm.nih.gov/pubmed/35023941
http://dx.doi.org/10.2147/CCID.S344867

Ejemplares similares